Recruiting

Chinese Herbal Medicine

Sponsor:

Center for Integrated Care

Code:

NCT04380870

Conditions

Coronavirus Infection

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Chinese Herbal Medicine

Study Details

Brief summary:

The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.

Conditions

Coronavirus Infection

Study ID

NCT04380870

Start date

May 11, 2020

Status verified date

Sep, 2021

Completion date

May 11, 2025

Anticipated

Primary completion date

Dec 11, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Eighteen year of age.
  • Experienced one or more of the following symptoms in the last 28 days: cough, fever, shortness of breath, diarrhea, nausea, or abdominal pain OR am at high risk of exposure.
  • Have a Primary Care Provider.

Exclusion Criteria:

  • Breastfeeding, pregnant, or expect that I might be pregnant.
  • Ineligible to receive a telehealth consult for any reason.
  • Unable to communicate in English verbally, and in writing.
  • Have an open legal case about my health.
  • Taking anticoagulants, immunosuppressants, antiseizure medications, antipsychotic medications or am in active cancer treatment
  • Taking medications with some risk of interaction with the herbal medicine. This will be determined at the time of the herbal consult by the clinic team.
  • Discretion of the practitioner or screener.

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Arms

Chinese Herbal Medicine

Chinese Herbal Medicine for suspected COVID-19 symptoms.

Interventions

Chinese Herbal Medicine

Chinese Herbal Medicine (CHM) has been used in the prevention and treatment of epidemic diseases dating back to the Han, Ming and Qing Dynasties and extending al the way through modern times. CHM formulas may contain plant elements of root, seed, back, stem or leaf in addition to minerals and other natural substances. All herbs dispensed in this trial will be from Spring Wind Herb Company.

Primary outcome measure

  • Patient reported main complaint [ Time Frame: 24 hours ]
  • Patient reported main complaint [ Time Frame: 48 hours ]
  • Patient reported main complaint [ Time Frame: 3 months ]
  • Patient reported main complaint [ Time Frame: 12 months ]

Central Contacts and Locations

Central contacts

Lisa A Taylor-Swanson, PhD

801-585-5486lisa.taylor-swanson@nurs.utah.edu

Lisa Conboy, DSc

617-718-1917lisaconboy@gmail.com

Locations

Seattle Intstitute of East Asian Medicine

Recruiting

Seattle, Washington, United States, 98108

Contacts

Katherine Taromina, DACM

206-517-4541ktaromina@sieam.edu

Principal Investigator:

Katherine Taromina, DACM

More Information

Sponsor

Center for Integrated Care

Last update posted

Sep 28, 2021

Last verified

Sep, 2021

Keywords

  • COVID-19 symptoms
  • Chinese Herbal Medicine
  • Cough
  • Shortness of Breath
  • Fatigue
  • Epidemic
  • Infectious Disease
  • Dyspnea
  • Diarrhea
  • Myalgia
  • Nausea
  • Fever
  • Pneumonia

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Center for Integrated Care on 2021-09-28.